TANDEM DIABETES CARE INC(TNDM)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

TANDEM DIABETES CARE INC (TNDM) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores TNDM at 42.8/100 on a 32-signal composite quality model, placing it at rank #1,998 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include free cash flow (22.8) and balance sheet strength (23.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 17.3/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), TANDEM DIABETES CARE INC reports quarterly revenue of $254.6M, net income of $-21.2M, an operating margin of -5.4%. Top institutional holders of TNDM by reported 13-F value include BlackRock, UBS Group AG, Sessa Capital IM, L.P., based on the most recent SEC filings. TNDM trades on the Nasdaq exchange and files with the SEC under CIK 1438133. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate TNDM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for TANDEM DIABETES CARE INC directly from SEC EDGAR.